Safilo Group SpA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IT0004604762
EUR
1.91
0.01 (0.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

  • Poor long term growth as Operating profit has grown by an annual rate -2.77% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 5.82
2

With ROE of -2.46%, it has a Very Expensive valuation with a 1.71 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 803 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.03

stock-summary
Return on Equity

-2.46%

stock-summary
Price to Book

2.00

Revenue and Profits:
Net Sales:
319 Million
(Quarterly Results - Dec 2015)
Net Profit:
-63 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
24.97%
0%
24.97%
6 Months
123.63%
0%
123.63%
1 Year
101.48%
0%
101.48%
2 Years
126.0%
0%
126.0%
3 Years
23.59%
0%
23.59%
4 Years
17.73%
0%
17.73%
5 Years
179.08%
0%
179.08%

Safilo Group SpA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
3.44%
EBIT Growth (5y)
-2.77%
EBIT to Interest (avg)
5.82
Debt to EBITDA (avg)
1.57
Net Debt to Equity (avg)
0.12
Sales to Capital Employed (avg)
2.57
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.77%
ROE (avg)
2.52%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.71
EV to EBIT
12.32
EV to EBITDA
7.13
EV to Capital Employed
1.69
EV to Sales
0.54
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.70%
ROE (Latest)
-2.46%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'15 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2015 is 2.60% vs 11.19% in Dec 2014",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2015 is -932.89% vs 222.58% in Dec 2014",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'15",
        "Dec'14",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "319.20",
          "val2": "311.10",
          "chgp": "2.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.60",
          "val2": "30.40",
          "chgp": "-22.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.90",
          "val2": "2.30",
          "chgp": "69.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-40.50",
          "val2": "4.50",
          "chgp": "-1,000.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-63.30",
          "val2": "7.60",
          "chgp": "-932.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "38.60%",
          "val2": "83.00%",
          "chgp": "-4.44%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -3.07% vs -4.83% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 183.52% vs -149.90% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "993.20",
          "val2": "1,024.70",
          "chgp": "-3.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "88.70",
          "val2": "74.10",
          "chgp": "19.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18.30",
          "val2": "20.60",
          "chgp": "-11.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.60",
          "val2": "-12.30",
          "chgp": "169.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "21.80",
          "val2": "-26.10",
          "chgp": "183.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "48.60%",
          "val2": "18.40%",
          "chgp": "3.02%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'15 - YoYstock-summary
Dec'15
Dec'14
Change(%)
Net Sales
319.20
311.10
2.60%
Operating Profit (PBDIT) excl Other Income
23.60
30.40
-22.37%
Interest
3.90
2.30
69.57%
Exceptional Items
-40.50
4.50
-1,000.00%
Consolidate Net Profit
-63.30
7.60
-932.89%
Operating Profit Margin (Excl OI)
38.60%
83.00%
-4.44%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2015 is 2.60% vs 11.19% in Dec 2014

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2015 is -932.89% vs 222.58% in Dec 2014

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
993.20
1,024.70
-3.07%
Operating Profit (PBDIT) excl Other Income
88.70
74.10
19.70%
Interest
18.30
20.60
-11.17%
Exceptional Items
8.60
-12.30
169.92%
Consolidate Net Profit
21.80
-26.10
183.52%
Operating Profit Margin (Excl OI)
48.60%
18.40%
3.02%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -3.07% vs -4.83% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 183.52% vs -149.90% in Dec 2023

stock-summaryCompany CV
About Safilo Group SpA stock-summary
stock-summary
Safilo Group SpA
Pharmaceuticals & Biotechnology
Safilo Group SpA is an Italy-based holding company of the Safilo Group (the Group). The Group manufactures sunglasses and prescription eyewear and is engaged in the design, production, wholesale and retail distribution of products for the eyewear market. The Group operates a number of brands grouped into own brands and licensed brands. The Group's own brands consists of house brand collections of optical frames, sunglasses, technical glasses, ski goggles and helmets and includes the Safilo, Carrera, Polaroid, Smith Optics and Oxydo brands. The licensed brands portfolio includes Alexander McQueen, Banana Republic, BOSS, BOSS Orange, Bottega Veneta, Celine, Dior, Fossil, Gucci, HUGO, J.Lo by Jennifer Lopez, Jimmy Choo, Juicy Couture, Kate Spade, Liz Claiborne, Marc Jacobs, Marc by Marc Jacobs, Max Mara, Max&Co, Pierre Cardin, Saint Laurent, Saks Fifth Avenue and Tommy Hilfiger. It operates through 30 owned subsidiaries in America, Europe and Asia and through a network of distributors.
Company Coordinates stock-summary
Company Details
Settima Strada, 15 , PADOVA None : 35129
stock-summary
Tel: 39 04 9698511139 049 6985766
stock-summary
Registrar Details